NEW YORK, Aug. 13, 2025 /PRNewswire/ — The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2025 Prix Galien USA Award nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup.” Winners will be announced during the Prix Galien USA Awards Ceremony on October 30, 2025, at the American Museum of Natural History in New York City.
“As Jury Chair, I am honored to recognize these exceptional nominees who exemplify the transformative power of innovation in medical technology, digital health, and entrepreneurship,” said Kenneth C. Frazier, Chair of the Jury, Prix Galien USA Awards Committee. “Their groundbreaking work represents the future of healthcare and our shared commitment to improving lives through scientific excellence.”
The 2025 Prix Galien USA nominees include products from the following categories: “Best Digital Health Solution” – 25 nominees; “Best Medical Technology” – 25 nominees; “Best Incubators, Accelerators and Equity” – 12 nominees, and “Best Startup” – 53 nominees.
To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years and demonstrate tremendous potential to improve human health. Sales data are not considered by the nominating committee in their award nominee selection, only science and health impact.
Best Digital Health Solution (Nominees)
AbbottNeuroSphere™ Virtual ClinicAdhereTechAidia SystemAll4Cure, Inc.All4Cure Platform, MyelomaMap (TM), TrialMatchMMAptar Digital HealthMigraine Buddy’s Weather and Trigger Advanced ReportsBeaconcureVerifyCleerlyCleerly LABS Plaque AnalysisClinical inkGlucoseReady (TM)DNAnexus + BoehringerIngelheim JointSubmission Project PRISM/Project CRYPTxEmpaticaEmpatica Health Monitoring PlatformEvinovaUnified Trial SolutionFirst Ascent Biomedical IncxDRIVE/DxPP – Ex Vivo Drug Response Identification & Validation Engine / Drug Prediction PlatformFuture Doctor IncMedGPT – AI Digital Twin of DoctorsHelfie AIHelfie AIMPAMyPsychAdmin – The only AI solution that frees Mental Health Practitioners from computers/admin so they can spend more time with their patients.MymeeMymee’s product is a proprietary personalized trial & care platform for rheumatic autoimmune patients who can no longer control disease flares with prescription therapies.NeuraLightNeuraLight platformOtsuka Precision HealthRejoynŌURAOura Ring 4Patientory, Inc.Patientory Digital Health Data WalletRapidAIRapid AneurysmRecursionRecursion Operating System (OS): end-to-end AI-driven drug discovery and development platformTECHMEDO Inc.Healthcare Operating SystemUniversity of Rochester – Wilmot Cancer InstituteUniversity of Rochester – Wilmot Cancer Institute’s HyperionWARD 24/7WARD Clinical Support System (WARD-CSS)WheelWheel Horizon
Best Medical Technology (Nominees)
AbbottEsprit™ BTK Everolimus Eluting Resorbable Scaffold SystemAbbottAVEIR™ Dual Chamber (DR) Leadless Pacemaker SystemAbbottTriClip™ G4 SystemAlconTOTAL30® Soft Contact LensesBeyond Air, Inc.LungFit® PHbioMérieuxBIOFIRE® SPOTFIRE® System and BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) PanelBioProtectBioProtect Balloon SpacerBody Vision Medical LTD.LungVision®Boston ScientificFARAPULSE™ Pulsed Field Ablation SystemCresilonTRAUMAGEL®Edwards LifesciencesEdwards SAPIEN 3 Ultra RESILIA Transcatheter Aortic Heart ValveEdwards LifesciencesEdwards EVOQUE Transcatheter Tricuspid Valve Replacement SystemENDOLOGIX LLCDETOUR SystemEstablishment Labs Holdings Inc.Motiva Flora® SmoothSilk® Tissue ExpanderGuardant HealthGuardant360® CDxImpulse DynamicsOptimizer® Smart Mini SystemMedtronicMiniMed™ 780G automated insulin delivery systemMedtronicSymplicity Spyral™ Renal Denervation SystemMedtronicInceptiv™ SCSOUR United CorporationTaiChiPro®PerspectumCoverScanPolareanXENOVIEW HPX SystemRefleXion MedicalRefleXion® X1 with SCINTIX® biology-guided radiotherapySmith & Nephew, Inc.CORI Surgical SystemTerumo AorticThoraflex Hybrid
Best Incubators, Accelerators and Equity (Nominees)
AVANT BIOAVANT BIO Fund II LPCalibr-Skaggs Institute for Innovative MedicinesCalibr-Skaggs Drug AcceleratorCornell UniversityCenter for Life Science VenturesCross-Border Impact VenturesWomen’s and Children’s Health Technology FundCube LabsCube LabsEIT HealthEIT Health AcceleratorEndless Frontier LabsEndless Frontier LabsMATTERSMILE HealthMayo ClinicMayo Clinic and Arizona State University Alliance for Health Care AcceleratorMcGill Dobson Centre for EntrepreneurshipMcGill Dobson Centre for EntrepreneurshipNucleateThe ActivatorOROT – CIUSSS West-Central MontrealOROT – Connected Health Incubator, CIUSSS West Central (Montréal)
Best Startup (Nominees)
Actipulse NeuroscienceActipulseAdaptilens, Inc.ADVANCED BIODESIGNALGA BIOLOGICSALGA BIOLOGICSAscidian TherapeuticsBigHat BiosciencesMilliner™Bitterroot BioBloqcube Inc.Canary MedicalCanary MedicalClick TherapeuticsPrescription Digital TherapeuticsCUTISS AGDren BioDuo OncologyDuo OncologyEsperto Medical, Inc.Ganymed RoboticsGanymed RoboticsGatehouse Bio, Inc.Geneos TherapeuticsGNOS-PV02+INO-9012 followed by intradermal electroporation. Personalized Therapeutic Cancer VaccineGleamerHope MedicineImaginostics, Inc.Immunis, Inc.Insilico MedicineIntrepid LabsKapsuleKapsule TerminalLEAF4Life, Inc.Libera Bio S.L.MPN TechnologymagAssist Co., Ltd.Mammoth BiosciencesManus NeurodynamicaNeuroMotor Pen™MediVIE TechMicron Biomedical, Inc.Navigation Sciences, Inc.Nona BiosciencesNospharmaParadigm TherapeuticsQubit PharmaceuticalsQubit PharmaceuticalsQuercisREGEnLIFEResuscitec GmbHSEED Therapeutics Inc.Seismic TherapeuticSFA Therapeutics, Inc.Shenzhen ReeToo Biotechnology Co., Ltd.SIMEDYSSIMEDYSSmartBioticAntimicrobial Management by SmartbioticStrand TherapeuticsSURGE TherapeuticsTargED Biopharmaceuticals B.V.Turbine Simulated Cell Technologies LimitedViCardia Therapeutics, Inc.Vocxi HealthMyBreathPrintXaTek Inc.ClotChipZest HealthZest Health
Bruno Cohen, Chairman of The Galien Foundation, commented, “We are honored to recognize this year’s outstanding Prix Galien USA nominees, whose innovation in medical technology, digital health, and entrepreneurship demonstrates the progress that moves healthcare forward. Their achievements reveal the extraordinary potential of science to change lives.”
Prix Galien Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup Committee 2025
Kenneth C. FRAZIER
Committee Chair, Former Chairman & CEO Merck
Roch DOLIVEUX
Honorary CEO, UCB
Dr. Mikael DOLSTEN
Chief Scientific Officer & President, Pfizer Research and Development
Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson
Penny HEATON
Global Therapeutic Area Head, Vaccines, Janssen
Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon
Joel S. MARCUS
Executive Chairman & Founder, Alexandria
Elias ZERHOUNI
Former Head of Global R&D, Sanofi
About The Galien FoundationThe Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. The late Professor Elie Wiesel, 1986 Peace Nobel Laureate, is The Honorary Founding President of The Galien Foundation.
The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries, Africa and an inaugural chapter established in India in 2024. The Prix Galien was created in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
For more information, visit www.galienfoundation.org.
SOURCE The Galien Foundation